Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
27.11
-0.05 (-0.18%)
At close: Nov 18, 2025, 4:00 PM EST
27.66
+0.55 (2.03%)
After-hours: Nov 18, 2025, 6:25 PM EST
Beta Bionics Stock Forecast
Stock Price Forecast
The 11 analysts that cover Beta Bionics stock have a consensus rating of "Strong Buy" and an average price target of $28.09, which forecasts a 3.61% increase in the stock price over the next year. The lowest target is $17 and the highest is $33.
Price Target: $28.09 (+3.61%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Beta Bionics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 7 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $26 → $33 | Strong Buy | Maintains | $26 → $33 | +21.73% | Oct 29, 2025 |
| Stifel | Stifel | Strong Buy Reiterates $26 → $31 | Strong Buy | Reiterates | $26 → $31 | +14.35% | Oct 29, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $28 → $32 | Strong Buy | Reiterates | $28 → $32 | +18.04% | Oct 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $26 → $32 | Buy | Reiterates | $26 → $32 | +18.04% | Oct 29, 2025 |
| Stifel | Stifel | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | -4.09% | Oct 21, 2025 |
Financial Forecast
Revenue This Year
99.08M
from 65.12M
Increased by 52.13%
Revenue Next Year
134.81M
from 99.08M
Increased by 36.07%
EPS This Year
-2.03
from -8.60
EPS Next Year
-1.83
from -2.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 102.8M | 151.2M | |||
| Avg | 99.1M | 134.8M | |||
| Low | 94.6M | 118.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 57.9% | 52.6% | |||
| Avg | 52.1% | 36.1% | |||
| Low | 45.2% | 19.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.93 | -1.33 | |||
| Avg | -2.03 | -1.83 | |||
| Low | -2.13 | -2.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.